the therapeutic effect of a combination therapy employing syngeneic anti-tumor immune t lymphocytes and either doxorubicin ( dx ) or cis-diamminedichloroplatinum ii ( ddp ) was tested on balb/c mice bearing a disseminated , weakly immunogenic lymphoma ( yc8 ) which metastasizes mainly to the liver .
C0024264
lymphocytes
C0024299
lymphoma